The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.
Oncotarget
Ahn, Sung-Min SM; Ansari, Adnan Ahmad AA; Kim, Jihun J; Kim, Deokhoon D; Chun, Sung-Min SM; Kim, Jiyun J; Kim, Tae Won TW; Park, Inja I; Yu, Chang-Sik CS; Jang, Se Jin SJ
Erlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Gross, Neil D ND; Bauman, Julie E JE; Gooding, William E WE; Denq, William W; Thomas, Sufi M SM; Wang, Lin L; Chiosea, Simion S; Hood, Brian L BL; Flint, Melanie S MS; Sun, Mai M; Conrads, Thomas P TP; Ferris, Robert L RL; Johnson, Jonas T JT; Kim, Seungwon S; Argiris, Athanassios A; Wirth, Lori L; Nikiforova, Marina N MN; Siegfried, Jill M JM; Grandis, Jennifer R JR
Publication Date: 2014-06-15
Variant appearance in text: PIK3CA: 1564G>A; E522K
Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists.
Cancer Cell
Kim, James J; Aftab, Blake T BT; Tang, Jean Y JY; Kim, Daniel D; Lee, Alex H AH; Rezaee, Melika M; Kim, Jynho J; Chen, Baozhi B; King, Emily M EM; Borodovsky, Alexandra A; Riggins, Gregory J GJ; Epstein, Ervin H EH; Beachy, Philip A PA; Rudin, Charles M CM